Connect with others who understand.

sign up log in
Resources
About MyBCTeam
Powered By

Navigating Treatments and Prognosis for Stage 3 Breast Cancer

Updated on October 03, 2022
View reactions
Medically reviewed by
Mark Levin, M.D.
Article written by
Aminah Wali, Ph.D.

During a breast cancer diagnosis, your doctor will determine the stage of your cancer. Stages range from 0 to 4, based on the size of the breast tumor and whether the cancer has spread to other organs. If your doctor determines you have stage 3 breast cancer, that indicates you have advanced breast cancer that has begun to impact the tissue surrounding the breast.

Knowing the stage can help your doctor choose the best treatment and predict your prognosis (estimated outlook).

How Is Breast Cancer Stage Determined?

Breast cancer is staged using the TNM staging system, where TNM stands for tumor, node, metastasis. The system looks at the following:

  • Tumor — How large is the primary tumor?
  • Node — Are there cancer cells in nearby or distant lymph nodes?
  • Metastasis — Has the cancer metastasized (spread) to other parts of the body?

A higher degree of cancer spread corresponds to more advanced-stage disease. Understanding the nature of the disease and determining the best treatment options also requires additional information, such as:

  • Hormone receptor status — Does the cancer contain estrogen receptors (ERs) or progesterone receptors (PRs), which are types of proteins?
  • Tumor grade — How do the abnormal cancer cells look compared to the normal cells?
  • Human epidermal growth factor receptor 2 (HER2) status — How high are your levels of the protein HER2?

What Is Stage 3 Breast Cancer?

Also called locally advanced breast cancer, stage 3 breast cancer is a more advanced form of invasive breast cancer. Cancer cells have spread from the milk ducts into the nearby lymph nodes, the skin of the breast, or the chest wall.

Stage 3 breast cancer may further be classified into substages — stage 3A, 3B, or 3C — depending on the size of the breast tumor and the extent of the cancer spread. Notably, breast cancer stages are sometimes referred to using Roman numerals, such as stage III instead of stage 3.

Stage 3A Breast Cancer

Stage 3A breast cancer refers to one of the following situations:

  • The doctor doesn’t find a tumor in the breast, or if there is a tumor, it may be of any size. Additionally, cancer is found in four to nine axillary lymph nodes (those that are in the armpit region) or in the lymph nodes closest to the breastbone
  • The tumor is larger than 5 centimeters, and there are small groups of breast cancer cells between 0.2 millimeters and 2 millimeters in size in the lymph nodes.
  • The tumor is larger than 5 centimeters, and the cancer has spread to one to three axillary lymph nodes or to the lymph nodes near the breastbone.

Stage 3B Breast Cancer

In stage 3B breast cancer, the cancer has spread to the lymph nodes and the chest wall, referring to the protective structures around the lungs. The cancer is also in the skin of the breast, resulting in ulcers or swelling.

Stage 3C Breast Cancer

In stage 3C breast cancer, there may be no sign of cancer in the breast. If there is a tumor, it may be any size and may have spread to the chest wall and/or the skin of the breast. Additionally, the cancer must have spread to one or more of the following places:

  • Ten or more axillary lymph nodes
  • Lymph nodes above or below the collarbone
  • The axillary lymph nodes or lymph nodes near the breastbone

Inflammatory Breast Cancer

Stage 3 breast cancer is classified as inflammatory breast cancer (IBC) when the cancer cells block vessels in the skin of the breast, causing the skin to feel warm and change in appearance.

Treatments for Stage 3 Breast Cancer

Stage 3 breast cancer treatment often starts with chemotherapy, followed by surgery. For cancers with certain genetic mutations, targeted drugs are also used in treatment.

Chemotherapy

Chemotherapy is often the first approach for treating stage 3 breast cancer. Chemotherapy is usually administered as neoadjuvant therapy, meaning it is given prior to surgery. This approach is beneficial in that it can:

  • Shrink the tumor to make it easier to remove
  • Test that a particular chemotherapy is effective
  • In some cases, allow for a less extensive surgical procedure

Mastectomy or Lumpectomy

A mastectomy, which is the removal of the breast tissue, is often required to treat stage 3 breast cancer. Alternatively, a lumpectomy — also referred to as breast-conserving surgery or partial mastectomy — involves the removal of only the breast tumor and some of the surrounding normal tissue.

Many people with stage 3 breast cancer are not eligible for a lumpectomy and likely need a mastectomy to get rid of the tumor completely. However, if neoadjuvant chemotherapy can shrink the tumor enough, a lumpectomy might become a viable option.

Following surgery, some people may choose to have reconstructive surgery to restore the appearance of their breasts.

Radiation

Radiation therapy is often administered following an operation to kill off any remaining breast cancer cells that may have been missed by treatment.

Lymph Node Dissection

Lymph nodes containing cancer cells must also be removed. An axillary lymph node dissection is done to remove the lymph nodes in the armpit. The procedure is usually performed at the same time as a mastectomy.

Hormonal Therapy

Some breast cancers contain proteins called hormone receptors on the surface of breast cancer cells. The hormone receptors that play a role in breast cancer progression are the estrogen receptors and progesterone receptors.

Hormone receptor-positive stage 3 breast cancers can be treated with hormonal therapy drugs such as tamoxifen or exemestane (sold as Aromasin), which specifically target the hormone receptors.

Targeted Therapy

Targeted therapy drugs work by stopping the function of a particular protein or group of proteins. HER2 is a protein that is present at high levels in some breast cancers and affects how the cancer grows. HER2-positive stage 3 cancers may be treated with drugs that specifically target the HER2 protein.

Immunotherapy

If breast cancer cells are negative for ER, PR, and HER2, the cancer is called triple-negative breast cancer. Triple-negative breast cancer is difficult to treat effectively with standard treatments, so newer forms of treatment like immunotherapy may be used to improve outcomes.

Immunotherapy drugs work by interacting with a person’s immune system so that it can recognize and fight the cancer cells. Pembrolizumab (sold as Keytruda) is an immunotherapy drug that can be used along with chemotherapy to treat triple-negative stage 3 breast cancer that has returned or spread after surgery.

Prognosis for Stage 3 Breast Cancer

Stage 3 breast cancer is an advanced stage disease, so prompt treatment is crucial for improving the prognosis.

Overall, stage 3 breast cancer has a somewhat favorable prognosis with a five-year survival rate as high as 86 percent. This means 86 percent of people with the condition live at least five years after being diagnosed. This rate can vary depending on the exact substage of cancer. For instance, IBC has a markedly lower survival rate, closer to 41 percent.

Hormonal therapy and other targeted drugs have helped to improve outcomes for cancers with specific genetic features. Some people may be encouraged to participate in clinical trials, which can advance the discovery of new effective treatments for stage 3 breast cancer.

Talk With Others Who Understand

MyBCTeam is the social network for people with breast cancer and their loved ones. On MyBCTeam, more than 58,000 members come together to ask questions, give advice, and share their stories with others who understand life with breast cancer.

Have you or a loved one been diagnosed with stage 3 breast cancer? Share your experiences in the comments below, or start a conversation by posting on MyBCTeam.

Updated on October 03, 2022
View reactions
All updates must be accompanied by text or a picture.
Mark Levin, M.D. is a hematology and oncology specialist with over 37 years of experience in internal medicine. Review provided by VeriMed Healthcare Network. Learn more about him here.
Aminah Wali, Ph.D. received her doctorate in genetics and molecular biology from the University of North Carolina at Chapel Hill. Learn more about her here.

Related articles

The genetic changes found in your breast tumor influence your prognosis and help your care team r...

What Is HER2? Understanding Cancer Genetics and Life Expectancy

The genetic changes found in your breast tumor influence your prognosis and help your care team r...
The survival rate for metastatic breast cancer (MBC) depends on many factors, including your age,...

What Is the Survival Rate for Metastatic Breast Cancer? Age and Life Expectancy

The survival rate for metastatic breast cancer (MBC) depends on many factors, including your age,...
You’ll have regular follow-ups with your doctor for the first five years after breast cancer trea...

Life After Breast Cancer: What To Expect 5 and 10 Years After Treatment

You’ll have regular follow-ups with your doctor for the first five years after breast cancer trea...
Triple-negative breast cancer (TNBC) is a fast-growing cancer that, after it is treated, may retu...

Triple-Negative Breast Cancer Recurrence Rate: 8 Things to Know

Triple-negative breast cancer (TNBC) is a fast-growing cancer that, after it is treated, may retu...
Breast cancer sometimes comes back, even if it can no longer be detected after you complete treat...

Which Types of Breast Cancer Have the Highest Recurrence Rate?

Breast cancer sometimes comes back, even if it can no longer be detected after you complete treat...
You have the right to seek a second opinion at any point during your breast cancer journey, from ...

5 Reasons To Seek a Second Opinion About Breast Cancer

You have the right to seek a second opinion at any point during your breast cancer journey, from ...

Recent articles

In welcome news to many who are immunocompromised, the U.S. Food and Drug Administration (FDA) re...

Next COVID-19 Vaccine Booster Dose Approved

In welcome news to many who are immunocompromised, the U.S. Food and Drug Administration (FDA) re...
The first targeted treatment for human epidermal growth factor receptor 2 (HER2)-positive breast ...

How Early-Stage HER2-Positive Breast Cancer Treatment Has Evolved

The first targeted treatment for human epidermal growth factor receptor 2 (HER2)-positive breast ...
Nurse Support | Top 3 Questions | Conversation Guide | Maintenance Therapy Breast cancer treatmen...

7 Ways Your Breast Cancer Nurse Can Support You

Nurse Support | Top 3 Questions | Conversation Guide | Maintenance Therapy Breast cancer treatmen...
Nurses are an important part of your health care team as you undergo treatment for human epiderma...

5 Ways Your Nurse Can Help During HER2-Positive Breast Cancer Treatment

Nurses are an important part of your health care team as you undergo treatment for human epiderma...
​Most people with breast cancer will undergo tests to determine whether their cancer is HER2-posi...

FISH and IHC Testing for HER2: 7 Things To Know

​Most people with breast cancer will undergo tests to determine whether their cancer is HER2-posi...
Advances in treatment for human epidermal growth factor receptor 2 (HER2)-positive breast cancer ...

Life After HER2-Positive Breast Cancer Treatment: 5 Ways To Stay Healthy

Advances in treatment for human epidermal growth factor receptor 2 (HER2)-positive breast cancer ...
MyBCTeam My breast cancer Team

Thank you for subscribing!

Become a member to get even more:

sign up for free

close